Details for New Drug Application (NDA): 050092
✉ Email this page to a colleague
NDA 050092 describes PATHOCIL, which is a drug marketed by Wyeth Ayerst and is included in two NDAs. Additional details are available on the PATHOCIL profile page.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for 050092
| Tradename: | PATHOCIL |
| Applicant: | Wyeth Ayerst |
| Ingredient: | dicloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050092
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 62.5MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
